nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoxetate—ABCC3—Etoposide—uterine cancer	0.236	0.335	CbGbCtD
Gadoxetate—ABCC3—Doxorubicin—uterine cancer	0.161	0.228	CbGbCtD
Gadoxetate—ABCC2—Carboplatin—uterine cancer	0.128	0.181	CbGbCtD
Gadoxetate—ABCC2—Etoposide—uterine cancer	0.107	0.152	CbGbCtD
Gadoxetate—ABCC2—Doxorubicin—uterine cancer	0.0732	0.104	CbGbCtD
Gadoxetate—Creatinine increased—Doxorubicin—uterine cancer	0.000489	0.00167	CcSEcCtD
Gadoxetate—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000489	0.00167	CcSEcCtD
Gadoxetate—Malaise—Dactinomycin—uterine cancer	0.000489	0.00167	CcSEcCtD
Gadoxetate—Salivary hypersecretion—Epirubicin—uterine cancer	0.000489	0.00167	CcSEcCtD
Gadoxetate—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000485	0.00166	CcSEcCtD
Gadoxetate—Fluid retention—Epirubicin—uterine cancer	0.000478	0.00163	CcSEcCtD
Gadoxetate—Blood urea increased—Epirubicin—uterine cancer	0.000475	0.00162	CcSEcCtD
Gadoxetate—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000467	0.0016	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000464	0.00158	CcSEcCtD
Gadoxetate—Injection site reaction—Doxorubicin—uterine cancer	0.000463	0.00158	CcSEcCtD
Gadoxetate—Hypersensitivity—Progesterone—uterine cancer	0.000461	0.00157	CcSEcCtD
Gadoxetate—Rash maculo-papular—Epirubicin—uterine cancer	0.000457	0.00156	CcSEcCtD
Gadoxetate—Discomfort—Dactinomycin—uterine cancer	0.000456	0.00156	CcSEcCtD
Gadoxetate—Salivary hypersecretion—Doxorubicin—uterine cancer	0.000452	0.00154	CcSEcCtD
Gadoxetate—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000451	0.00154	CcSEcCtD
Gadoxetate—Asthenia—Progesterone—uterine cancer	0.000449	0.00153	CcSEcCtD
Gadoxetate—Hypoaesthesia—Etoposide—uterine cancer	0.000449	0.00153	CcSEcCtD
Gadoxetate—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000448	0.00153	CcSEcCtD
Gadoxetate—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000448	0.00153	CcSEcCtD
Gadoxetate—Pruritus—Progesterone—uterine cancer	0.000443	0.00151	CcSEcCtD
Gadoxetate—Oedema—Dactinomycin—uterine cancer	0.000442	0.00151	CcSEcCtD
Gadoxetate—Fluid retention—Doxorubicin—uterine cancer	0.000442	0.00151	CcSEcCtD
Gadoxetate—Infection—Dactinomycin—uterine cancer	0.00044	0.0015	CcSEcCtD
Gadoxetate—Blood urea increased—Doxorubicin—uterine cancer	0.00044	0.0015	CcSEcCtD
Gadoxetate—Sepsis—Epirubicin—uterine cancer	0.000437	0.00149	CcSEcCtD
Gadoxetate—Diarrhoea—Progesterone—uterine cancer	0.000428	0.00146	CcSEcCtD
Gadoxetate—Phlebitis—Epirubicin—uterine cancer	0.000424	0.00145	CcSEcCtD
Gadoxetate—Rash maculo-papular—Doxorubicin—uterine cancer	0.000423	0.00144	CcSEcCtD
Gadoxetate—Anorexia—Dactinomycin—uterine cancer	0.000422	0.00144	CcSEcCtD
Gadoxetate—Cardiac disorder—Etoposide—uterine cancer	0.000418	0.00143	CcSEcCtD
Gadoxetate—Flushing—Etoposide—uterine cancer	0.000418	0.00143	CcSEcCtD
Gadoxetate—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000418	0.00143	CcSEcCtD
Gadoxetate—Dizziness—Progesterone—uterine cancer	0.000414	0.00141	CcSEcCtD
Gadoxetate—Angiopathy—Etoposide—uterine cancer	0.000409	0.0014	CcSEcCtD
Gadoxetate—Immune system disorder—Etoposide—uterine cancer	0.000407	0.00139	CcSEcCtD
Gadoxetate—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000407	0.00139	CcSEcCtD
Gadoxetate—Mediastinal disorder—Etoposide—uterine cancer	0.000406	0.00139	CcSEcCtD
Gadoxetate—Chills—Etoposide—uterine cancer	0.000404	0.00138	CcSEcCtD
Gadoxetate—Sepsis—Doxorubicin—uterine cancer	0.000404	0.00138	CcSEcCtD
Gadoxetate—Cardiac failure congestive—Epirubicin—uterine cancer	0.000403	0.00137	CcSEcCtD
Gadoxetate—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000401	0.00137	CcSEcCtD
Gadoxetate—Vomiting—Progesterone—uterine cancer	0.000398	0.00136	CcSEcCtD
Gadoxetate—Renal failure acute—Epirubicin—uterine cancer	0.000396	0.00135	CcSEcCtD
Gadoxetate—Rash—Progesterone—uterine cancer	0.000395	0.00135	CcSEcCtD
Gadoxetate—Dermatitis—Progesterone—uterine cancer	0.000394	0.00135	CcSEcCtD
Gadoxetate—Phlebitis—Doxorubicin—uterine cancer	0.000392	0.00134	CcSEcCtD
Gadoxetate—Headache—Progesterone—uterine cancer	0.000392	0.00134	CcSEcCtD
Gadoxetate—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000388	0.00132	CcSEcCtD
Gadoxetate—Decreased appetite—Dactinomycin—uterine cancer	0.000385	0.00131	CcSEcCtD
Gadoxetate—Dysgeusia—Etoposide—uterine cancer	0.000384	0.00131	CcSEcCtD
Gadoxetate—Renal impairment—Epirubicin—uterine cancer	0.000384	0.00131	CcSEcCtD
Gadoxetate—Fatigue—Dactinomycin—uterine cancer	0.000382	0.0013	CcSEcCtD
Gadoxetate—Back pain—Etoposide—uterine cancer	0.00038	0.0013	CcSEcCtD
Gadoxetate—Anaphylactoid reaction—Epirubicin—uterine cancer	0.000377	0.00129	CcSEcCtD
Gadoxetate—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000375	0.00128	CcSEcCtD
Gadoxetate—Cerebrovascular accident—Epirubicin—uterine cancer	0.000373	0.00127	CcSEcCtD
Gadoxetate—Cardiac failure congestive—Doxorubicin—uterine cancer	0.000373	0.00127	CcSEcCtD
Gadoxetate—Nausea—Progesterone—uterine cancer	0.000372	0.00127	CcSEcCtD
Gadoxetate—Renal failure acute—Doxorubicin—uterine cancer	0.000366	0.00125	CcSEcCtD
Gadoxetate—Feeling abnormal—Dactinomycin—uterine cancer	0.000365	0.00124	CcSEcCtD
Gadoxetate—Ill-defined disorder—Etoposide—uterine cancer	0.000364	0.00124	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000362	0.00123	CcSEcCtD
Gadoxetate—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000361	0.00123	CcSEcCtD
Gadoxetate—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000358	0.00122	CcSEcCtD
Gadoxetate—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000357	0.00122	CcSEcCtD
Gadoxetate—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000355	0.00121	CcSEcCtD
Gadoxetate—Renal impairment—Doxorubicin—uterine cancer	0.000355	0.00121	CcSEcCtD
Gadoxetate—Malaise—Etoposide—uterine cancer	0.000354	0.00121	CcSEcCtD
Gadoxetate—Face oedema—Epirubicin—uterine cancer	0.000353	0.0012	CcSEcCtD
Gadoxetate—Vertigo—Etoposide—uterine cancer	0.000353	0.0012	CcSEcCtD
Gadoxetate—Abdominal pain—Dactinomycin—uterine cancer	0.00035	0.00119	CcSEcCtD
Gadoxetate—Body temperature increased—Dactinomycin—uterine cancer	0.00035	0.00119	CcSEcCtD
Gadoxetate—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.000349	0.00119	CcSEcCtD
Gadoxetate—Loss of consciousness—Etoposide—uterine cancer	0.000345	0.00118	CcSEcCtD
Gadoxetate—Cerebrovascular accident—Doxorubicin—uterine cancer	0.000345	0.00118	CcSEcCtD
Gadoxetate—Cough—Etoposide—uterine cancer	0.000342	0.00117	CcSEcCtD
Gadoxetate—Blood creatinine increased—Epirubicin—uterine cancer	0.000342	0.00117	CcSEcCtD
Gadoxetate—Convulsion—Etoposide—uterine cancer	0.00034	0.00116	CcSEcCtD
Gadoxetate—Dehydration—Epirubicin—uterine cancer	0.00034	0.00116	CcSEcCtD
Gadoxetate—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000337	0.00115	CcSEcCtD
Gadoxetate—Chest pain—Etoposide—uterine cancer	0.000334	0.00114	CcSEcCtD
Gadoxetate—Hypokalaemia—Epirubicin—uterine cancer	0.000332	0.00113	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000332	0.00113	CcSEcCtD
Gadoxetate—Discomfort—Etoposide—uterine cancer	0.00033	0.00113	CcSEcCtD
Gadoxetate—Face oedema—Doxorubicin—uterine cancer	0.000326	0.00111	CcSEcCtD
Gadoxetate—Hypersensitivity—Dactinomycin—uterine cancer	0.000326	0.00111	CcSEcCtD
Gadoxetate—Anaphylactic shock—Etoposide—uterine cancer	0.00032	0.00109	CcSEcCtD
Gadoxetate—Infection—Etoposide—uterine cancer	0.000318	0.00109	CcSEcCtD
Gadoxetate—Abdominal distension—Epirubicin—uterine cancer	0.000318	0.00108	CcSEcCtD
Gadoxetate—Asthenia—Dactinomycin—uterine cancer	0.000317	0.00108	CcSEcCtD
Gadoxetate—Blood creatinine increased—Doxorubicin—uterine cancer	0.000317	0.00108	CcSEcCtD
Gadoxetate—Dysphagia—Epirubicin—uterine cancer	0.000316	0.00108	CcSEcCtD
Gadoxetate—Dehydration—Doxorubicin—uterine cancer	0.000314	0.00107	CcSEcCtD
Gadoxetate—Tachycardia—Etoposide—uterine cancer	0.000313	0.00107	CcSEcCtD
Gadoxetate—Skin disorder—Etoposide—uterine cancer	0.000311	0.00106	CcSEcCtD
Gadoxetate—Hyperhidrosis—Etoposide—uterine cancer	0.00031	0.00106	CcSEcCtD
Gadoxetate—Hypokalaemia—Doxorubicin—uterine cancer	0.000308	0.00105	CcSEcCtD
Gadoxetate—Anorexia—Etoposide—uterine cancer	0.000305	0.00104	CcSEcCtD
Gadoxetate—Bronchitis—Epirubicin—uterine cancer	0.000304	0.00104	CcSEcCtD
Gadoxetate—Diarrhoea—Dactinomycin—uterine cancer	0.000303	0.00103	CcSEcCtD
Gadoxetate—Hypotension—Etoposide—uterine cancer	0.000299	0.00102	CcSEcCtD
Gadoxetate—Abdominal distension—Doxorubicin—uterine cancer	0.000294	0.001	CcSEcCtD
Gadoxetate—Dysphagia—Doxorubicin—uterine cancer	0.000292	0.000997	CcSEcCtD
Gadoxetate—Paraesthesia—Etoposide—uterine cancer	0.000288	0.000981	CcSEcCtD
Gadoxetate—Dyspnoea—Etoposide—uterine cancer	0.000286	0.000974	CcSEcCtD
Gadoxetate—Vomiting—Dactinomycin—uterine cancer	0.000281	0.00096	CcSEcCtD
Gadoxetate—Bronchitis—Doxorubicin—uterine cancer	0.000281	0.000959	CcSEcCtD
Gadoxetate—Rash—Dactinomycin—uterine cancer	0.000279	0.000952	CcSEcCtD
Gadoxetate—Decreased appetite—Etoposide—uterine cancer	0.000278	0.00095	CcSEcCtD
Gadoxetate—Renal failure—Epirubicin—uterine cancer	0.000277	0.000944	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Etoposide—uterine cancer	0.000276	0.000944	CcSEcCtD
Gadoxetate—Fatigue—Etoposide—uterine cancer	0.000276	0.000942	CcSEcCtD
Gadoxetate—Constipation—Etoposide—uterine cancer	0.000274	0.000935	CcSEcCtD
Gadoxetate—Conjunctivitis—Epirubicin—uterine cancer	0.000274	0.000934	CcSEcCtD
Gadoxetate—Feeling abnormal—Etoposide—uterine cancer	0.000264	0.000901	CcSEcCtD
Gadoxetate—Nausea—Dactinomycin—uterine cancer	0.000263	0.000897	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Etoposide—uterine cancer	0.000262	0.000894	CcSEcCtD
Gadoxetate—Renal failure—Doxorubicin—uterine cancer	0.000256	0.000874	CcSEcCtD
Gadoxetate—Urticaria—Etoposide—uterine cancer	0.000254	0.000868	CcSEcCtD
Gadoxetate—Rhinitis—Epirubicin—uterine cancer	0.000253	0.000864	CcSEcCtD
Gadoxetate—Abdominal pain—Etoposide—uterine cancer	0.000253	0.000864	CcSEcCtD
Gadoxetate—Body temperature increased—Etoposide—uterine cancer	0.000253	0.000864	CcSEcCtD
Gadoxetate—Conjunctivitis—Doxorubicin—uterine cancer	0.000253	0.000864	CcSEcCtD
Gadoxetate—Hypoaesthesia—Epirubicin—uterine cancer	0.000251	0.000858	CcSEcCtD
Gadoxetate—Connective tissue disorder—Epirubicin—uterine cancer	0.000248	0.000847	CcSEcCtD
Gadoxetate—Hypersensitivity—Etoposide—uterine cancer	0.000236	0.000805	CcSEcCtD
Gadoxetate—Cardiac disorder—Epirubicin—uterine cancer	0.000235	0.0008	CcSEcCtD
Gadoxetate—Flushing—Epirubicin—uterine cancer	0.000235	0.0008	CcSEcCtD
Gadoxetate—Rhinitis—Doxorubicin—uterine cancer	0.000234	0.0008	CcSEcCtD
Gadoxetate—Hypoaesthesia—Doxorubicin—uterine cancer	0.000233	0.000794	CcSEcCtD
Gadoxetate—Asthenia—Etoposide—uterine cancer	0.00023	0.000784	CcSEcCtD
Gadoxetate—Connective tissue disorder—Doxorubicin—uterine cancer	0.00023	0.000784	CcSEcCtD
Gadoxetate—Angiopathy—Epirubicin—uterine cancer	0.000229	0.000782	CcSEcCtD
Gadoxetate—Immune system disorder—Epirubicin—uterine cancer	0.000228	0.000779	CcSEcCtD
Gadoxetate—Mediastinal disorder—Epirubicin—uterine cancer	0.000228	0.000777	CcSEcCtD
Gadoxetate—Chills—Epirubicin—uterine cancer	0.000227	0.000774	CcSEcCtD
Gadoxetate—Pruritus—Etoposide—uterine cancer	0.000227	0.000773	CcSEcCtD
Gadoxetate—Arrhythmia—Epirubicin—uterine cancer	0.000226	0.00077	CcSEcCtD
Gadoxetate—Diarrhoea—Etoposide—uterine cancer	0.000219	0.000748	CcSEcCtD
Gadoxetate—Flushing—Doxorubicin—uterine cancer	0.000217	0.00074	CcSEcCtD
Gadoxetate—Cardiac disorder—Doxorubicin—uterine cancer	0.000217	0.00074	CcSEcCtD
Gadoxetate—Flatulence—Epirubicin—uterine cancer	0.000217	0.00074	CcSEcCtD
Gadoxetate—Dysgeusia—Epirubicin—uterine cancer	0.000215	0.000735	CcSEcCtD
Gadoxetate—Back pain—Epirubicin—uterine cancer	0.000213	0.000726	CcSEcCtD
Gadoxetate—Angiopathy—Doxorubicin—uterine cancer	0.000212	0.000724	CcSEcCtD
Gadoxetate—Dizziness—Etoposide—uterine cancer	0.000212	0.000723	CcSEcCtD
Gadoxetate—Immune system disorder—Doxorubicin—uterine cancer	0.000211	0.000721	CcSEcCtD
Gadoxetate—Mediastinal disorder—Doxorubicin—uterine cancer	0.000211	0.000719	CcSEcCtD
Gadoxetate—Chills—Doxorubicin—uterine cancer	0.00021	0.000716	CcSEcCtD
Gadoxetate—Arrhythmia—Doxorubicin—uterine cancer	0.000209	0.000713	CcSEcCtD
Gadoxetate—Vision blurred—Epirubicin—uterine cancer	0.000207	0.000707	CcSEcCtD
Gadoxetate—Ill-defined disorder—Epirubicin—uterine cancer	0.000204	0.000696	CcSEcCtD
Gadoxetate—Vomiting—Etoposide—uterine cancer	0.000204	0.000695	CcSEcCtD
Gadoxetate—Agitation—Epirubicin—uterine cancer	0.000202	0.00069	CcSEcCtD
Gadoxetate—Rash—Etoposide—uterine cancer	0.000202	0.000689	CcSEcCtD
Gadoxetate—Dermatitis—Etoposide—uterine cancer	0.000202	0.000688	CcSEcCtD
Gadoxetate—Headache—Etoposide—uterine cancer	0.000201	0.000685	CcSEcCtD
Gadoxetate—Flatulence—Doxorubicin—uterine cancer	0.000201	0.000684	CcSEcCtD
Gadoxetate—Dysgeusia—Doxorubicin—uterine cancer	0.000199	0.00068	CcSEcCtD
Gadoxetate—Malaise—Epirubicin—uterine cancer	0.000198	0.000677	CcSEcCtD
Gadoxetate—Vertigo—Epirubicin—uterine cancer	0.000198	0.000674	CcSEcCtD
Gadoxetate—Syncope—Epirubicin—uterine cancer	0.000197	0.000673	CcSEcCtD
Gadoxetate—Back pain—Doxorubicin—uterine cancer	0.000197	0.000672	CcSEcCtD
Gadoxetate—Palpitations—Epirubicin—uterine cancer	0.000194	0.000663	CcSEcCtD
Gadoxetate—Loss of consciousness—Epirubicin—uterine cancer	0.000193	0.00066	CcSEcCtD
Gadoxetate—Cough—Epirubicin—uterine cancer	0.000192	0.000655	CcSEcCtD
Gadoxetate—Vision blurred—Doxorubicin—uterine cancer	0.000192	0.000655	CcSEcCtD
Gadoxetate—Convulsion—Epirubicin—uterine cancer	0.000191	0.00065	CcSEcCtD
Gadoxetate—Nausea—Etoposide—uterine cancer	0.00019	0.000649	CcSEcCtD
Gadoxetate—Ill-defined disorder—Doxorubicin—uterine cancer	0.000189	0.000644	CcSEcCtD
Gadoxetate—Chest pain—Epirubicin—uterine cancer	0.000187	0.000639	CcSEcCtD
Gadoxetate—Agitation—Doxorubicin—uterine cancer	0.000187	0.000638	CcSEcCtD
Gadoxetate—Anxiety—Epirubicin—uterine cancer	0.000187	0.000637	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000186	0.000635	CcSEcCtD
Gadoxetate—Discomfort—Epirubicin—uterine cancer	0.000185	0.000631	CcSEcCtD
Gadoxetate—Malaise—Doxorubicin—uterine cancer	0.000184	0.000626	CcSEcCtD
Gadoxetate—Dry mouth—Epirubicin—uterine cancer	0.000183	0.000625	CcSEcCtD
Gadoxetate—Vertigo—Doxorubicin—uterine cancer	0.000183	0.000624	CcSEcCtD
Gadoxetate—Syncope—Doxorubicin—uterine cancer	0.000183	0.000623	CcSEcCtD
Gadoxetate—Palpitations—Doxorubicin—uterine cancer	0.00018	0.000614	CcSEcCtD
Gadoxetate—Anaphylactic shock—Epirubicin—uterine cancer	0.00018	0.000613	CcSEcCtD
Gadoxetate—Oedema—Epirubicin—uterine cancer	0.00018	0.000613	CcSEcCtD
Gadoxetate—Loss of consciousness—Doxorubicin—uterine cancer	0.000179	0.00061	CcSEcCtD
Gadoxetate—Infection—Epirubicin—uterine cancer	0.000178	0.000609	CcSEcCtD
Gadoxetate—Cough—Doxorubicin—uterine cancer	0.000178	0.000606	CcSEcCtD
Gadoxetate—Shock—Epirubicin—uterine cancer	0.000177	0.000603	CcSEcCtD
Gadoxetate—Convulsion—Doxorubicin—uterine cancer	0.000176	0.000602	CcSEcCtD
Gadoxetate—Nervous system disorder—Epirubicin—uterine cancer	0.000176	0.000601	CcSEcCtD
Gadoxetate—Tachycardia—Epirubicin—uterine cancer	0.000175	0.000598	CcSEcCtD
Gadoxetate—Skin disorder—Epirubicin—uterine cancer	0.000174	0.000595	CcSEcCtD
Gadoxetate—Hyperhidrosis—Epirubicin—uterine cancer	0.000174	0.000592	CcSEcCtD
Gadoxetate—Chest pain—Doxorubicin—uterine cancer	0.000173	0.000591	CcSEcCtD
Gadoxetate—Anxiety—Doxorubicin—uterine cancer	0.000173	0.000589	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000172	0.000587	CcSEcCtD
Gadoxetate—Discomfort—Doxorubicin—uterine cancer	0.000171	0.000584	CcSEcCtD
Gadoxetate—Anorexia—Epirubicin—uterine cancer	0.000171	0.000584	CcSEcCtD
Gadoxetate—Dry mouth—Doxorubicin—uterine cancer	0.000169	0.000578	CcSEcCtD
Gadoxetate—Hypotension—Epirubicin—uterine cancer	0.000168	0.000572	CcSEcCtD
Gadoxetate—Anaphylactic shock—Doxorubicin—uterine cancer	0.000166	0.000567	CcSEcCtD
Gadoxetate—Oedema—Doxorubicin—uterine cancer	0.000166	0.000567	CcSEcCtD
Gadoxetate—Infection—Doxorubicin—uterine cancer	0.000165	0.000563	CcSEcCtD
Gadoxetate—Shock—Doxorubicin—uterine cancer	0.000163	0.000558	CcSEcCtD
Gadoxetate—Nervous system disorder—Doxorubicin—uterine cancer	0.000163	0.000556	CcSEcCtD
Gadoxetate—Tachycardia—Doxorubicin—uterine cancer	0.000162	0.000553	CcSEcCtD
Gadoxetate—Skin disorder—Doxorubicin—uterine cancer	0.000161	0.000551	CcSEcCtD
Gadoxetate—Paraesthesia—Epirubicin—uterine cancer	0.000161	0.00055	CcSEcCtD
Gadoxetate—Hyperhidrosis—Doxorubicin—uterine cancer	0.000161	0.000548	CcSEcCtD
Gadoxetate—Dyspnoea—Epirubicin—uterine cancer	0.00016	0.000546	CcSEcCtD
Gadoxetate—Anorexia—Doxorubicin—uterine cancer	0.000158	0.00054	CcSEcCtD
Gadoxetate—Decreased appetite—Epirubicin—uterine cancer	0.000156	0.000533	CcSEcCtD
Gadoxetate—Hypotension—Doxorubicin—uterine cancer	0.000155	0.00053	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000155	0.000529	CcSEcCtD
Gadoxetate—Fatigue—Epirubicin—uterine cancer	0.000155	0.000528	CcSEcCtD
Gadoxetate—Constipation—Epirubicin—uterine cancer	0.000154	0.000524	CcSEcCtD
Gadoxetate—Paraesthesia—Doxorubicin—uterine cancer	0.000149	0.000509	CcSEcCtD
Gadoxetate—Dyspnoea—Doxorubicin—uterine cancer	0.000148	0.000505	CcSEcCtD
Gadoxetate—Feeling abnormal—Epirubicin—uterine cancer	0.000148	0.000505	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Epirubicin—uterine cancer	0.000147	0.000501	CcSEcCtD
Gadoxetate—Decreased appetite—Doxorubicin—uterine cancer	0.000144	0.000493	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000143	0.000489	CcSEcCtD
Gadoxetate—Fatigue—Doxorubicin—uterine cancer	0.000143	0.000489	CcSEcCtD
Gadoxetate—Urticaria—Epirubicin—uterine cancer	0.000143	0.000487	CcSEcCtD
Gadoxetate—Constipation—Doxorubicin—uterine cancer	0.000142	0.000485	CcSEcCtD
Gadoxetate—Body temperature increased—Epirubicin—uterine cancer	0.000142	0.000484	CcSEcCtD
Gadoxetate—Abdominal pain—Epirubicin—uterine cancer	0.000142	0.000484	CcSEcCtD
Gadoxetate—Feeling abnormal—Doxorubicin—uterine cancer	0.000137	0.000467	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000136	0.000464	CcSEcCtD
Gadoxetate—Hypersensitivity—Epirubicin—uterine cancer	0.000132	0.000451	CcSEcCtD
Gadoxetate—Urticaria—Doxorubicin—uterine cancer	0.000132	0.00045	CcSEcCtD
Gadoxetate—Abdominal pain—Doxorubicin—uterine cancer	0.000131	0.000448	CcSEcCtD
Gadoxetate—Body temperature increased—Doxorubicin—uterine cancer	0.000131	0.000448	CcSEcCtD
Gadoxetate—Asthenia—Epirubicin—uterine cancer	0.000129	0.00044	CcSEcCtD
Gadoxetate—Pruritus—Epirubicin—uterine cancer	0.000127	0.000433	CcSEcCtD
Gadoxetate—Diarrhoea—Epirubicin—uterine cancer	0.000123	0.000419	CcSEcCtD
Gadoxetate—Hypersensitivity—Doxorubicin—uterine cancer	0.000122	0.000418	CcSEcCtD
Gadoxetate—Asthenia—Doxorubicin—uterine cancer	0.000119	0.000407	CcSEcCtD
Gadoxetate—Dizziness—Epirubicin—uterine cancer	0.000119	0.000405	CcSEcCtD
Gadoxetate—Pruritus—Doxorubicin—uterine cancer	0.000118	0.000401	CcSEcCtD
Gadoxetate—Vomiting—Epirubicin—uterine cancer	0.000114	0.00039	CcSEcCtD
Gadoxetate—Diarrhoea—Doxorubicin—uterine cancer	0.000114	0.000388	CcSEcCtD
Gadoxetate—Rash—Epirubicin—uterine cancer	0.000113	0.000386	CcSEcCtD
Gadoxetate—Dermatitis—Epirubicin—uterine cancer	0.000113	0.000386	CcSEcCtD
Gadoxetate—Headache—Epirubicin—uterine cancer	0.000112	0.000384	CcSEcCtD
Gadoxetate—Dizziness—Doxorubicin—uterine cancer	0.00011	0.000375	CcSEcCtD
Gadoxetate—Nausea—Epirubicin—uterine cancer	0.000107	0.000364	CcSEcCtD
Gadoxetate—Vomiting—Doxorubicin—uterine cancer	0.000106	0.00036	CcSEcCtD
Gadoxetate—Rash—Doxorubicin—uterine cancer	0.000105	0.000357	CcSEcCtD
Gadoxetate—Dermatitis—Doxorubicin—uterine cancer	0.000105	0.000357	CcSEcCtD
Gadoxetate—Headache—Doxorubicin—uterine cancer	0.000104	0.000355	CcSEcCtD
Gadoxetate—Nausea—Doxorubicin—uterine cancer	9.87e-05	0.000337	CcSEcCtD
Gadoxetate—ABCC3—ABC-family proteins mediated transport—ABCC9—uterine cancer	5.33e-05	0.0689	CbGpPWpGaD
Gadoxetate—ABCC4—ABC-family proteins mediated transport—ABCC9—uterine cancer	5.01e-05	0.0648	CbGpPWpGaD
Gadoxetate—SLCO1B3—Bile acid and bile salt metabolism—AKR1C1—uterine cancer	4.34e-05	0.056	CbGpPWpGaD
Gadoxetate—ABCC2—ABC-family proteins mediated transport—ABCC9—uterine cancer	4.23e-05	0.0546	CbGpPWpGaD
Gadoxetate—ABCC3—Bile acid and bile salt metabolism—AKR1C1—uterine cancer	3.91e-05	0.0506	CbGpPWpGaD
Gadoxetate—ABCC3—Fluoropyrimidine Activity—RRM2—uterine cancer	3.74e-05	0.0483	CbGpPWpGaD
Gadoxetate—ABCC4—Fluoropyrimidine Activity—RRM2—uterine cancer	3.52e-05	0.0454	CbGpPWpGaD
Gadoxetate—SLCO1B3—Bile acid and bile salt metabolism—AKR1C3—uterine cancer	3.34e-05	0.0431	CbGpPWpGaD
Gadoxetate—ABCC3—Bile acid and bile salt metabolism—AKR1C3—uterine cancer	3.01e-05	0.0389	CbGpPWpGaD
Gadoxetate—SLCO1B1—Bile acid and bile salt metabolism—AKR1C1—uterine cancer	2.91e-05	0.0376	CbGpPWpGaD
Gadoxetate—SLCO1B3—vagina—uterine cancer	2.86e-05	0.108	CbGeAlD
Gadoxetate—SLCO1B1—renal system—uterine cancer	2.29e-05	0.086	CbGeAlD
Gadoxetate—SLCO1B1—Bile acid and bile salt metabolism—AKR1C3—uterine cancer	2.24e-05	0.029	CbGpPWpGaD
Gadoxetate—ABCC3—decidua—uterine cancer	2.21e-05	0.0831	CbGeAlD
Gadoxetate—ABCC3—renal system—uterine cancer	2.17e-05	0.0816	CbGeAlD
Gadoxetate—ABCC3—Fluoropyrimidine Activity—MTHFR—uterine cancer	1.89e-05	0.0244	CbGpPWpGaD
Gadoxetate—SLCO1B1—female reproductive system—uterine cancer	1.83e-05	0.0689	CbGeAlD
Gadoxetate—ABCC4—renal system—uterine cancer	1.79e-05	0.0674	CbGeAlD
Gadoxetate—ABCC4—Fluoropyrimidine Activity—MTHFR—uterine cancer	1.78e-05	0.023	CbGpPWpGaD
Gadoxetate—ABCC3—female reproductive system—uterine cancer	1.74e-05	0.0654	CbGeAlD
Gadoxetate—ABCC2—renal system—uterine cancer	1.73e-05	0.0652	CbGeAlD
Gadoxetate—ABCC4—uterus—uterine cancer	1.6e-05	0.06	CbGeAlD
Gadoxetate—ABCC3—female gonad—uterine cancer	1.58e-05	0.0595	CbGeAlD
Gadoxetate—ABCC4—female reproductive system—uterine cancer	1.43e-05	0.0539	CbGeAlD
Gadoxetate—ABCC2—female reproductive system—uterine cancer	1.39e-05	0.0522	CbGeAlD
Gadoxetate—ABCC4—female gonad—uterine cancer	1.31e-05	0.0491	CbGeAlD
Gadoxetate—ABCC3—NRF2 pathway—NFE2L2—uterine cancer	1.17e-05	0.0152	CbGpPWpGaD
Gadoxetate—ABCC3—NRF2 pathway—GPX3—uterine cancer	1.12e-05	0.0145	CbGpPWpGaD
Gadoxetate—ABCC4—NRF2 pathway—NFE2L2—uterine cancer	1.1e-05	0.0143	CbGpPWpGaD
Gadoxetate—ABCC4—NRF2 pathway—GPX3—uterine cancer	1.05e-05	0.0136	CbGpPWpGaD
Gadoxetate—ABCC3—lymph node—uterine cancer	1.02e-05	0.0382	CbGeAlD
Gadoxetate—ABCC2—NRF2 pathway—NFE2L2—uterine cancer	9.32e-06	0.012	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	8.98e-06	0.0116	CbGpPWpGaD
Gadoxetate—ABCC2—NRF2 pathway—GPX3—uterine cancer	8.89e-06	0.0115	CbGpPWpGaD
Gadoxetate—ABCC4—lymph node—uterine cancer	8.39e-06	0.0316	CbGeAlD
Gadoxetate—ABCC2—lymph node—uterine cancer	8.12e-06	0.0305	CbGeAlD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	8.1e-06	0.0105	CbGpPWpGaD
Gadoxetate—ABCC3—Fluoropyrimidine Activity—TP53—uterine cancer	7.18e-06	0.00927	CbGpPWpGaD
Gadoxetate—ABCC4—Fluoropyrimidine Activity—TP53—uterine cancer	6.75e-06	0.00872	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—STAR—uterine cancer	6.49e-06	0.00839	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	6.49e-06	0.00839	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—ABCC9—uterine cancer	6.17e-06	0.00798	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	6.03e-06	0.0078	CbGpPWpGaD
Gadoxetate—ABCC4—Ectoderm Differentiation—FGFR2—uterine cancer	5.88e-06	0.0076	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—STAR—uterine cancer	5.86e-06	0.00757	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	5.86e-06	0.00757	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—ABCC9—uterine cancer	5.57e-06	0.0072	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—ABCC9—uterine cancer	5.24e-06	0.00677	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	4.77e-06	0.00616	CbGpPWpGaD
Gadoxetate—ABCC4—Ectoderm Differentiation—CCL2—uterine cancer	4.43e-06	0.00572	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—ABCC9—uterine cancer	4.42e-06	0.00571	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—VEGFA—uterine cancer	4.4e-06	0.00568	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	4.36e-06	0.00564	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	4.36e-06	0.00564	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	4.3e-06	0.00556	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—uterine cancer	4.19e-06	0.00541	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—ABCC9—uterine cancer	4.15e-06	0.00536	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—NDUFB11—uterine cancer	4e-06	0.00517	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—SRD5A2—uterine cancer	4e-06	0.00517	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.89e-06	0.00502	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.67e-06	0.00474	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—NDUFB11—uterine cancer	3.61e-06	0.00466	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—SRD5A2—uterine cancer	3.61e-06	0.00466	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.51e-06	0.00453	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—IRF1—uterine cancer	3.4e-06	0.00439	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.31e-06	0.00428	CbGpPWpGaD
Gadoxetate—ABCC4—Ectoderm Differentiation—CTNNB1—uterine cancer	3.23e-06	0.00417	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.2e-06	0.00414	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—STAR—uterine cancer	2.89e-06	0.00374	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—AKR1B1—uterine cancer	2.89e-06	0.00374	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.86e-06	0.00369	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—NDUFB11—uterine cancer	2.69e-06	0.00347	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SRD5A2—uterine cancer	2.69e-06	0.00347	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.61e-06	0.00337	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—AKR1B1—uterine cancer	2.61e-06	0.00337	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—STAR—uterine cancer	2.61e-06	0.00337	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.58e-06	0.00333	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.47e-06	0.00318	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—POLD1—uterine cancer	2.27e-06	0.00293	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—AKR1C1—uterine cancer	2.12e-06	0.00274	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—POLD1—uterine cancer	2.05e-06	0.00265	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	1.95e-06	0.00252	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—AKR1B1—uterine cancer	1.94e-06	0.00251	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—STAR—uterine cancer	1.94e-06	0.00251	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.92e-06	0.00248	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—AKR1C1—uterine cancer	1.92e-06	0.00247	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—RRM2—uterine cancer	1.89e-06	0.00244	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—DCN—uterine cancer	1.84e-06	0.00237	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP11A1—uterine cancer	1.73e-06	0.00224	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—RRM2—uterine cancer	1.71e-06	0.00221	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—DCN—uterine cancer	1.66e-06	0.00214	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—AKR1C3—uterine cancer	1.63e-06	0.00211	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP11A1—uterine cancer	1.56e-06	0.00202	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—POLD1—uterine cancer	1.52e-06	0.00197	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	1.52e-06	0.00197	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—AKR1C3—uterine cancer	1.47e-06	0.0019	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—AKR1C1—uterine cancer	1.43e-06	0.00184	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—STK11—uterine cancer	1.27e-06	0.00164	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP19A1—uterine cancer	1.27e-06	0.00164	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—RRM2—uterine cancer	1.27e-06	0.00164	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—AKT1—uterine cancer	1.24e-06	0.00161	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—DCN—uterine cancer	1.23e-06	0.00159	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.19e-06	0.00154	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP11A1—uterine cancer	1.16e-06	0.0015	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—STK11—uterine cancer	1.15e-06	0.00148	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP19A1—uterine cancer	1.15e-06	0.00148	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.14e-06	0.00147	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—AKR1C3—uterine cancer	1.1e-06	0.00142	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.08e-06	0.00139	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—EP300—uterine cancer	1.06e-06	0.00137	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.03e-06	0.00133	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—VEGFA—uterine cancer	1.01e-06	0.0013	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—NRAS—uterine cancer	9.93e-07	0.00128	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—MTHFR—uterine cancer	9.57e-07	0.00124	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—MTHFR—uterine cancer	8.63e-07	0.00112	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—STK11—uterine cancer	8.55e-07	0.0011	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP19A1—uterine cancer	8.55e-07	0.0011	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—KRAS—uterine cancer	8.55e-07	0.0011	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	8.43e-07	0.00109	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.03e-07	0.00104	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PIK3CA—uterine cancer	7.86e-07	0.00101	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.66e-07	0.000989	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.61e-07	0.000983	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—TP53—uterine cancer	7.6e-07	0.000982	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—HRAS—uterine cancer	7.27e-07	0.000939	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—MTHFR—uterine cancer	6.43e-07	0.00083	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—AKT1—uterine cancer	6.42e-07	0.000829	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.66e-07	0.000732	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PTEN—uterine cancer	5.32e-07	0.000688	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—EP300—uterine cancer	5.08e-07	0.000656	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PTEN—uterine cancer	4.8e-07	0.00062	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—EP300—uterine cancer	4.58e-07	0.000592	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIK3CA—uterine cancer	3.75e-07	0.000485	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PTEN—uterine cancer	3.58e-07	0.000462	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—EP300—uterine cancer	3.41e-07	0.000441	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIK3CA—uterine cancer	3.39e-07	0.000438	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—AKT1—uterine cancer	3.07e-07	0.000396	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—AKT1—uterine cancer	2.77e-07	0.000358	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIK3CA—uterine cancer	2.52e-07	0.000326	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—AKT1—uterine cancer	2.06e-07	0.000266	CbGpPWpGaD
